IO Biotech, Inc. (IOBT)
NASDAQ: IOBT · Real-Time Price · USD
0.2901
-0.0262 (-8.28%)
Jan 30, 2026, 4:00 PM EST - Market closed
IO Biotech Market Cap
IO Biotech has a market cap or net worth of $20.87 million as of January 30, 2026. Its market cap has decreased by -59.89% in one year.
Market Cap
20.87M
Enterprise Value
8.33M
1-Year Change
-59.89%
Ranking
Category
Stock Price
$0.29
Market Cap Chart
Since the IPO on November 5, 2021, IO Biotech's market cap has decreased from $369.28M to $20.87M, a decrease of -94.35%. That is a compound annual growth rate of -49.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 20.87M | -52.36% |
| Dec 31, 2025 | 43.81M | -27.72% |
| Dec 31, 2024 | 60.61M | -51.06% |
| Dec 29, 2023 | 123.86M | 86.88% |
| Dec 30, 2022 | 66.28M | -64.06% |
| Dec 31, 2021 | 184.42M | -50.06% |
| Nov 5, 2021 | 369.28M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CollPlant Biotechnologies | 24.66M |
| FibroBiologics | 23.81M |
| Vistagen Therapeutics | 23.13M |
| Intensity Therapeutics | 22.94M |
| NanoViricides | 22.65M |
| Polyrizon | 22.47M |
| Jupiter Neurosciences | 21.72M |
| Neuphoria Therapeutics | 21.56M |